[Opioid peptides as ligands of neuronal receptors].
D000818:Animals; D001714:Bipolar Disorder / Q000188:drug therapy / Q000503:physiopathology*; D000242:Cyclic AMP / Q000378:metabolism; D004558:Electric Stimulation; D004723:Endorphins / Q000134:cerebrospinal fluid / Q000502:physiology*; D004743:Enkephalin, Leucine / Q000494:pharmacology; D004744:Enkephalin, Methionine / Q000378:metabolism / Q000494:pharmacology; D006624:Hippocampus / Q000187:drug effects / Q000502:physiology; D006801:Humans; D066298:In Vitro Techniques; D008214:Lymphocytes / Q000378:metabolism; D008564:Membrane Potentials / Q000187:drug effects; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology / Q000627:therapeutic use; D009474:Neurons / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D011957:Receptors, Opioid / Q000378:metabolism; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000503:physiopathology*; D012907:Smoking; D012908:Snails
D004723:Endorphins; D011957:Receptors, Opioid; D009270:Naloxone; D004744:Enkephalin, Methionine; D004743:Enkephalin, Leucine; D009020:Morphine; D000242:Cyclic AMP
Opioidnye peptidy kak ligandy neĭronal'nykh retseptorov.